NCT05559892Active, not recruiting
Conditional Cash Transfer Intervention to Improve T2DM
Conditional Cash Transfer Intervention to Improve Health Outcomes Among Inner-City African Americans With T2DM
Source: ClinicalTrials.gov · Last updated 1 Oct 2025
Brief summary (registry, in English)
This study will test the preliminary efficacy of diabetes-tailored CCT (DM-CCT), which will be conditional on participating in biweekly (every two weeks), nurse-led, virtual diabetes education/skills training and stress/coping intervention compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in 100 inner city AAs with poorly controlled T2DM using an RCT design. The aims of the proposed study include: AIM 1: Test the preliminary efficacy of the DM-CCT intervention on glycemic control and quality of life for inner-city AAs with T2DM. AIM 2: Test the preliminary efficacy of the DM-CCT intervention on self-care behaviors and psychological health for inner-city AAs with T2DM. AIM 3: Estimate the cost of delivery of the DM-CCT and UCT interventions in preparation for future cost effectiveness analysis.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 26 Sept 2022
- Start date
- 1 Nov 2022
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- State University of New York at Buffalo
- Diseases
- Type 2 diabetes
- NCT number
- NCT05559892
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Nov 2022 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Alcohol or drug abuse/dependency
Other illness
- Mental confusion on interview suggesting significant dementia
- Active psychosis or acute mental disorder
- Participation in other diabetes clinical trials
Other
- Life expectancy \<6 months
Who the study is looking for
- Age ≥18 years
- Self-report as African American
- Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
- Residence in inner city zip codes
- Income greater or equal to133% of federal poverty level or Medicaid eligible
- Able to communicate in English.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State University at Buffalo Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.